ZOLAR is a first-in-human, proof-of-concept and biodistribution trial that uses positron emission tomography (PET) to evaluate olaratumab, a monoclonal antibody, as a therapeutic radiopharmaceutical ...
It affects muscles and soft tissue," says Goldenberg. And unlike arthritis and other rheumatic (arthritis-like) disorders, fibromyalgia isn't a disease characterized by inflammation. In fact ...
Chemotherapy plus local therapy improved overall survival and disease-free survival when compared to local therapy alone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback